Topic: Risperdal

Last week, Johnson & Johnson agreed to pay $158 million to settle a lawsuit filed by the Texas attorney general, who charged the health care giant...

A.M. Vitals: J&J to Settle Texas Risperdal Suit For $158 Million

J&J Settles With Texas: Johnson & Johnson said it would pay $158 million to settle claims by Texas that the company promoted its antipsychotic drug...
By Jef Feeley and Margaret Cronin Fisk Jan. 19 (Bloomberg) -- Johnson & Johnson agreed to settle Texas officials' claims that the drugmaker...
A lawsuit in which Texas accused Johnson & Johnson of plundering the state Medicaid program by overstating the safety of an expensive...

Antipsychotics

In schizophrenia, antipsychotic medications are proven effective in treating acute psychosis and reducing the risk of future psychotic episodes...
Johnson & Johnson (JNJ), like many of the largest and strongest US companies, is trading at a discount to its historical valuation, creating an...
Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson (JNJ), recalled about 16,000 bottles of its Risperdal schizophrenia drug on...
Johnson & Johnson (JNJ) says it plan to seek approval for 11 new products and more than 30 important product line extensions between 2011 and 2015...
The U.S. wants Johnson & Johnson (NYSE:JNJ) to pay $1 billion to settle a multi-year probe into whether the company falsely marketed the...
Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit. Mar. 4, 2011 (Marketwire) - . . AUSTIN, TX -...